The data was further validated by demonstrating reduced LEF/TCF reporter activity in WNT5A-expressing breast cancer cells, proposing that WNT5A not only suppresses β-catenin protein expression but also inhibits its downstream transcriptional activity in breast cancer cells. This evidence concerns the gene WNT5A and breast carcinoma.